Expression Therap...
- Org chart
- Gabriela Denning, Ph.D
Gabriela Denning, Ph.D
Vice President of Research & Development
Dr. Denning received her Ph.D. in Biochemistry from The University of Texas Medical Branch. Her post-doctoral studies at The Scripps Research Institute under Dr. Peter K. Vogt, focused on understanding novel mechanisms of PTEN tumor suppressor function. Currently, Dr. Denning oversees all pre-clinical research and development efforts at Expression Therapeutics. Dr. Denning oversees many company roles including directing the development and execution of NIH STTR and SBIR funded programs in lentiviral and adeno-associated viral gene therapy of hemophilia A as well as recombinant ET3i immune tolerance induction for FVIII inhibitors.
Roles at Expression Therapeutics
Vice President of Research & Development
Current role
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at Expression Therapeutics
My pet peeves
My communication style
No teams